Serum levels of S100B in patients with chronic schizophrenia during treatment augmentation with sarcosine: results of the double-blind, randomized, placebo-controlled PULSAR study.
Saved in:
| Title: | Serum levels of S100B in patients with chronic schizophrenia during treatment augmentation with sarcosine: results of the double-blind, randomized, placebo-controlled PULSAR study. |
|---|---|
| Authors: | Pawlak A; Department of Affective and Psychotic Disorders, Medical University of Łódź, Łódź, Poland., Wysokiński A; Department of Old Age Psychiatry and Psychotic Disorders, Medical University of Łódź, Łódź, Poland., Strzelecki D; Department of Affective and Psychotic Disorders, Medical University of Łódź, Łódź, Poland. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2026 Mar 18; Vol. 17, pp. 1705310. Date of Electronic Publication: 2026 Mar 18 (Print Publication: 2026). |
| Publication Type: | Clinical Trial; Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
